Project for Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan.
Cancer Gene Ther. 2024 May;31(5):736-745. doi: 10.1038/s41417-024-00745-z. Epub 2024 Mar 1.
Breast cancer is a heterogeneous disease, and breast cancer cell lines are invaluable for studying this heterogeneity. However, the epigenetic diversity across these cell lines remains poorly understood. In this study, we performed genome-wide chromatin accessibility analysis on 23 breast cancer cell lines, including 2 estrogen receptor (ER)-positive/human epidermal growth factor receptor 2 (HER2)-negative (ER+/HER2-), 3 ER+/HER2+, 3 HER2+, and 15 triple-negative breast cancer (TNBC) lines. These cell lines were classified into three groups based on their chromatin accessibility: the receptor-positive group (Group-P), TNBC basal group (Group-B), and TNBC mesenchymal group (Group-M). Motif enrichment analysis revealed that only Group-P exhibited coenrichment of forkhead box A1 (FOXA1) and grainyhead-like 2 (GRHL2) motifs, whereas Group-B was characterized by the presence of the GRHL2 motif without FOXA1. Notably, Group-M did not show enrichment of either FOXA1 or GRHL2 motifs. Furthermore, gene ontology analysis suggested that group-specific accessible regions were associated with their unique lineage characteristics. To investigate the epigenetic landscape regulatory roles of FOXA1 and GRHL2, we performed knockdown experiments targeting FOXA1 and GRHL2, followed by assay for transposase-accessible chromatin sequencing analysis. The findings revealed that FOXA1 maintains Group-P-specific regions while suppressing Group-B-specific regions in Group-P cells. In contrast, GRHL2 preserves commonly accessible regions shared between Group-P and Group-B in Group-B cells, suggesting that FOXA1 and GRHL2 play a pivotal role in preserving distinct chromatin accessibility patterns for each group. Specifically, FOXA1 distinguishes between receptor-positive and TNBC cell lines, whereas GRHL2 distinguishes between basal-like and mesenchymal subtypes in TNBC lines.
乳腺癌是一种异质性疾病,乳腺癌细胞系对于研究这种异质性非常有价值。然而,这些细胞系之间的表观遗传多样性仍了解甚少。在这项研究中,我们对 23 种乳腺癌细胞系进行了全基因组染色质可及性分析,包括 2 种雌激素受体(ER)阳性/人表皮生长因子受体 2(HER2)阴性(ER+/HER2-)、3 种 ER+/HER2+、3 种 HER2+和 15 种三阴性乳腺癌(TNBC)细胞系。这些细胞系根据染色质可及性分为三组:受体阳性组(Group-P)、TNBC 基底组(Group-B)和 TNBC 间质组(Group-M)。基序富集分析显示,只有 Group-P 表现出叉头框 A1(FOXA1)和粒状头样 2(GRHL2)基序的共富集,而 Group-B 的特征是存在 GRHL2 基序而没有 FOXA1。值得注意的是,Group-M 既没有 FOXA1 也没有 GRHL2 基序的富集。此外,基因本体分析表明,特定组的可及区域与它们独特的谱系特征有关。为了研究 FOXA1 和 GRHL2 的表观遗传景观调节作用,我们针对 FOXA1 和 GRHL2 进行了敲低实验,随后进行了转座酶可及染色质测序分析。结果表明,FOXA1 在 Group-P 细胞中维持 Group-P 特异性区域,同时抑制 Group-B 特异性区域。相反,GRHL2 在 Group-B 细胞中保留了 Group-P 和 Group-B 之间共同可及的区域,这表明 FOXA1 和 GRHL2 在维持每个组的独特染色质可及性模式方面发挥着关键作用。具体来说,FOXA1 区分受体阳性和 TNBC 细胞系,而 GRHL2 区分 TNBC 细胞系中的基底样和间质亚型。